ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0N4A Oasmia Pharmaceutical Ab

5.2065
0.00 (0.00%)
May 16 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20172018201920202020202120222023
SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)
Total Revenue 390k4.77M2.22M201.95M2.76M68.48M4.68M9.52M
Operating Income -140.68M-103.24M-151.33M-30.41M-131.7M-128.84M-364.35M-132.17M
Pre Tax Income -160.24M-118.01M-169.06M-43.36M-140.27M-132.72M-365.72M-128.74M
Net Income -160.24M-118.01M-201.89M-10.53M-140.27M-132.72M-365.72M-128.74M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.271-0.669-0.898-0.023-0.313-0.296-0.68-0.239
EBIT -140.68M-103.24M-151.33M-30.41M-131.7M-128.84M-364.35M-132.17M
EBITDA -136.18M-98.45M-119.74M-10.38M-102.77M-99.97M-99.19M-74.8M